Day: November 7, 2025

ROAD TOWN, British Virgin Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has exercised 24,000,000 common share purchase warrants (each, a “Warrant”) of Altamira Gold Corp. (the “Issuer” or “Altamira”) at an exercise price of CAD$0.20 per Warrant. Each Warrant was exercisable for one common share (each, a “Share”) of the Issuer. Immediately prior to the acquisition of the securities described in this press release, Aura owned 30,000,000 Shares and 27,000,000 Warrants, representing approximately 11.3% of the issued and outstanding Shares on a non-diluted basis and approximately 19.5% of the issued and outstanding Shares on a fully diluted basis. Immediately following the transaction that triggered the requirement to file this press release, Aura...

TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF)  (“Discovery” or the “Company”) today to reported initial results from four key exploration projects at the Company’s Porcupine Complex, including Hoyle Pond Mine, Borden Mine and Pamour Mine, as well as at Owl Creek, a high-priority target located approximately three kilometres west of Hoyle Pond.  The results include assays from a combined total of 85 holes1 (27,640 metres (“m”)), completed between April 2025 and October 2025, which are part of an overall 140,000 m program being completed. The Company also provided an update on recently initiated drilling programs at the Dome Mine and TVZ Zone adjacent to Hoyle Pond, two key growth projects which have the potential to significantly grow production from the Porcupine Complex. Key HighlightsExcellent...

CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) — Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing agreement with Finceramica Faenza S.p.A., an innovative Italian biomaterials company. The three-year extension strengthens the longstanding partnership, granting Kelyniam expanded access to Finceramica’s advanced product portfolio, including SINTlife, a next-generation fully resorbable synthetic graft made of substituted magnesium hydroxyapatite nanocrystals, available in injectable putty form, Surgery V-Connect a Smart Augmented Reality System and other products SINTlife product is expected to receive FDA clearance within 2 years, targeting markets estimated to be 10 times larger than the current custom cranial implant sector. This...